Followers

Thursday, 10 September 2015

Off-label cases against the FDA move forward

Amarin begins legally promoting off-label uses of its prescription fish-oil drug, while Pacira sues the FDA over the label for its pain drug, Exparel.

from Most popular articles from Medical Marketing and Media http://ift.tt/1L4gEqZ
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)